These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

250 related articles for article (PubMed ID: 25574917)

  • 1. Disputed rpoB mutations can frequently cause important rifampicin resistance among new tuberculosis patients.
    Van Deun A; Aung KJ; Hossain A; de Rijk P; Gumusboga M; Rigouts L; de Jong BC
    Int J Tuberc Lung Dis; 2015 Feb; 19(2):185-90. PubMed ID: 25574917
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of Xpert MTB/RIF Assay and GenoType MTBDRplus DNA Probes for Detection of Mutations Associated with Rifampicin Resistance in Mycobacterium tuberculosis.
    Rahman A; Sahrin M; Afrin S; Earley K; Ahmed S; Rahman SM; Banu S
    PLoS One; 2016; 11(4):e0152694. PubMed ID: 27054344
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reevaluating Rifampicin Breakpoint Concentrations for Mycobacterium tuberculosis Isolates with Disputed
    Wang W; Liu R; Yao C; Huo F; Shang Y; Zhang X; Wang Y; Xue Z; Ma L; Pang Y
    Microbiol Spectr; 2022 Feb; 10(1):e0208721. PubMed ID: 35107324
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Retrospective Analysis of False-Positive and Disputed Rifampin Resistance Xpert MTB/RIF Assay Results in Clinical Samples from a Referral Hospital in Hunan, China.
    Hu P; Zhang H; Fleming J; Zhu G; Zhang S; Wang Y; Liu F; Yi S; Chen Z; Chen Z; Liu B; Gong D; Wan L; Wang X; Tan Y; Bai L; Bi L
    J Clin Microbiol; 2019 Apr; 57(4):. PubMed ID: 30674578
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Absence of hybridization with the wild-type and mutant rpoB probes in the Genotype MTBDRplus assay detects 'disputed' rifampicin mutations.
    Abanda NN; Djieugoué JY; Khadka VS; Pefura-Yone EW; Mbacham WF; Vernet G; Penlap VM; Deng Y; Eyangoh SI; Taylor DW; Leke RGF
    Clin Microbiol Infect; 2018 Jul; 24(7):781.e1-781.e3. PubMed ID: 29217277
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Xpert® MTB/RIF assay evaluation in South Korea, a country with an intermediate tuberculosis burden.
    Kim SY; Kim H; Kim SY; Ra EK; Joo SI; Shin S; Seong MW; Yoo CG; Kim EC; Park SS
    Int J Tuberc Lung Dis; 2012 Nov; 16(11):1471-6. PubMed ID: 22981162
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of the GenoType MTBDRplus assay for rifampin and isoniazid susceptibility testing of Mycobacterium tuberculosis strains and clinical specimens.
    Hillemann D; Rüsch-Gerdes S; Richter E
    J Clin Microbiol; 2007 Aug; 45(8):2635-40. PubMed ID: 17537937
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of two commercial assays for the characterization of rpoB mutations in Mycobacterium tuberculosis and description of new mutations conferring weak resistance to rifampicin.
    Hauck Y; Fabre M; Vergnaud G; Soler C; Pourcel C
    J Antimicrob Chemother; 2009 Aug; 64(2):259-62. PubMed ID: 19520715
    [TBL] [Abstract][Full Text] [Related]  

  • 9. False-positive rifampicin resistance on Xpert® MTB/RIF caused by a silent mutation in the rpoB gene.
    Mathys V; van de Vyvere M; de Droogh E; Soetaert K; Groenen G
    Int J Tuberc Lung Dis; 2014 Oct; 18(10):1255-7. PubMed ID: 25216843
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of the Genotype® MTBDRplus assay as a tool for drug resistance surveys.
    Rigouts L; Hoza AS; De Rijk P; Torrea G; Chonde TM; Basra D; Zignol M; van Leth F; Egwaga SM; Van Deun A
    Int J Tuberc Lung Dis; 2011 Jul; 15(7):959-65. PubMed ID: 21682972
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Validation of the line-probe assay for rapid detection of rifampicin-resistant Mycobacterium tuberculosis in Vietnam.
    Shah NS; Lan NT; Huyen MN; Laserson K; Iademarco MF; Binkin N; Wells C; Varma JK
    Int J Tuberc Lung Dis; 2009 Feb; 13(2):247-52. PubMed ID: 19146755
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel rapid PCR for the detection of Ile491Phe rpoB mutation of Mycobacterium tuberculosis, a rifampicin-resistance-conferring mutation undetected by commercial assays.
    André E; Goeminne L; Colmant A; Beckert P; Niemann S; Delmee M
    Clin Microbiol Infect; 2017 Apr; 23(4):267.e5-267.e7. PubMed ID: 27998822
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genotyping of mutations detected with GeneXpert.
    N'guessan Kouassi K; Riccardo A; Dutoziet Christian C; André G; Férilaha C; Hortense SA; Jean-Marc A; Daniela Maria C; Mireille D
    Int J Mycobacteriol; 2016 Jun; 5(2):142-7. PubMed ID: 27242224
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Evaluation of the genotype MTBDR assay for rapid detection of rifampin and isoniazid resistance in clinical Mycobacterium tuberculosis complex clinical isolates].
    Aslan G; Tezcan S; Emekdaş G
    Mikrobiyol Bul; 2009 Apr; 43(2):217-26. PubMed ID: 19621606
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Variable ability of rapid tests to detect Mycobacterium tuberculosis rpoB mutations conferring phenotypically occult rifampicin resistance.
    Torrea G; Ng KCS; Van Deun A; André E; Kaisergruber J; Ssengooba W; Desmaretz C; Gabriels S; Driesen M; Diels M; Asnong S; Fissette K; Gumusboga M; Rigouts L; Affolabi D; Joloba M; De Jong BC
    Sci Rep; 2019 Aug; 9(1):11826. PubMed ID: 31413308
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rifampin drug resistance tests for tuberculosis: challenging the gold standard.
    Van Deun A; Aung KJ; Bola V; Lebeke R; Hossain MA; de Rijk WB; Rigouts L; Gumusboga A; Torrea G; de Jong BC
    J Clin Microbiol; 2013 Aug; 51(8):2633-40. PubMed ID: 23761144
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Xpert(®) MTB/RIF detection of rifampin resistance and time to treatment initiation in Harare, Zimbabwe.
    Metcalfe JZ; Makumbirofa S; Makamure B; Sandy C; Bara W; Mason P; Hopewell PC
    Int J Tuberc Lung Dis; 2016 Jul; 20(7):882-9. PubMed ID: 27287639
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Advantages of the AdvanSure MDR-TB GenoBlot assay containing disputed rpoB mutation-specific probes in a routine clinical laboratory setting.
    Yoo IY; Huh HJ; Kang OK; Jhun BW; Koh WJ; Lee NY
    Respir Med; 2019 Jan; 146():71-75. PubMed ID: 30665521
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Performance comparison of four methods for detecting multidrug-resistant Mycobacterium tuberculosis strains.
    Al-Mutairi NM; Ahmad S; Mokaddas E
    Int J Tuberc Lung Dis; 2011 Jan; 15(1):110-5. PubMed ID: 21276306
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use of smear-positive samples to assess the PCR-based genotype MTBDR assay for rapid, direct detection of the Mycobacterium tuberculosis complex as well as its resistance to isoniazid and rifampin.
    Somoskovi A; Dormandy J; Mitsani D; Rivenburg J; Salfinger M
    J Clin Microbiol; 2006 Dec; 44(12):4459-63. PubMed ID: 17035488
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.